SCHEMBL5048325

SCHEMBL5048325

CNC(COC(C)(C)C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRN P28799 1/20 0.50
▸ SORT1 Q99523 1/20 0.50
▸ MAPK1 P28482 1/20 0.41
▸ KEAP1 Q14145 2/20 0.37
▸ PPARA Q07869 3/20 0.35
▸ PYGL P06737 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ BACE1 P56817 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ PPARG P37231 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ THPO P40225 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1693987 1.00 GRN (0.50) GRNSORT1MAPK1KEAP1PPARA
SCHEMBL1693084 1.00 GRN (0.50) GRNSORT1MAPK1KEAP1PPARA
Hydrochloric Acid SCHEMBL2490304 0.98 GRN (0.49) GRNSORT1MAPK1KEAP1PPARA
SCHEMBL19230492 0.83 MAPK1 (0.41) GRNSORT1MAPK1
SCHEMBL1361481 0.83 MAPK1 (0.41) GRNSORT1MAPK1KEAP1BACE1
SCHEMBL28528204 0.83 MAPK1 (0.41) GRNSORT1MAPK1KEAP1BACE1
SCHEMBL19230491 0.83 MAPK1 (0.41) GRNSORT1MAPK1
SCHEMBL18515857 0.82 GRN (0.56) GRNSORT1MAPK1KEAP1PPARA
SCHEMBL978015 0.82 GRN (0.49) GRNSORT1MAPK1KEAP1PPARA
SCHEMBL13711068 0.82 MAPK1 (0.40) GRNSORT1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100491345-C Process for liquid phase synthesis of N-fluorenyl-methoxy-carbonyl-N-methyl-O-tertiary butyl serine GL BIOCHEM SHANGHAI LTD (CN) 2009-05-27 — — CN claimed
CN-1837189-A Process for liquid phase synthesis of N-fluorenyl-methoxy-carbonyl-N-methyl-O-tertiary butyl serine GL BIOCHEM SHANGHAI LTD (CN) 2006-09-27 — — CN claimed
US-12624002-B2 Dimers for use in synthesis of peptidomimetics THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-05-12 — — US disclosed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 — — US disclosed
US-12595233-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-07 — — US disclosed
US-12351573-B2 Compounds for use in synthesis of peptidomimetics THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2025-07-08 — — US disclosed
WO-2025128985-A1 SULFOXIDE AND SULFONE DERIVATIVES OF THIOCARBAZATES AS SYNTHONS FOR AZAPEPTIDES SYNTHESIS AND PROCESS OF USING SAME THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2025-06-19 — — WO disclosed
CN-114126619-B Compounds for the synthesis of peptidomimetics 范因斯坦医学研究院 2024-03-15 — — CN disclosed
EP-3784669-B1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMA (US) 2023-10-25 — — EP disclosed
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-10-05 — — US disclosed
US-20230159450-A1 DIMERS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 2023-05-25 — — US disclosed
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2020-11-12 — — US disclosed
US-20190322673-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2019-10-24 — — US disclosed
US-20170267648-A1 SUBSTITUTED URACILS AS CHYMASE INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-21 — — US disclosed
US-9695131-B2 Substituted uracils as chymase inhibitors BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-07-04 — — US disclosed
US-20160244415-A1 SUBSTITUTED URACILS AS CHYMASE INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-08-25 — — US disclosed
EP-2813512-A1 PEPTIDE-COMPOUND CYCLIZATION METHOD Chugai Seiyaku Kabushiki Kaisha (JP) 2014-12-17 — — EP disclosed
US-20090258381-A1 Methods for Determining the Cleavability of Substrates FORSCHUNGSZENTRUM BORSTEL (DE) 2009-10-15 — — US disclosed
US-20090104633-A1 Kit for Highly Sensitive Detection Assays VYZKUMNY USTAV VETERINARNIHO LEKARSTVI (CZ) 2009-04-23 — — US disclosed
US-7368424-B2 Acylated nonadepsipeptides AICURIS GMBH & CO. KG (DE) 2008-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12351573-B2 Compounds for use in synthesis of peptidomimetics DNPEP, NPEPPS, PAM GRN 2407/4885SORT1 2254/4885MAPK1 3722/4885
US-20170267648-A1 SUBSTITUTED URACILS AS CHYMASE INHIBITORS CMA1, UNG, TYMP GRN 1400/4885SORT1 3819/4885MAPK1 4447/4885
US-12624002-B2 Dimers for use in synthesis of peptidomimetics GLUL, ARGLU1, ASNS GRN 852/4885SORT1 4244/4885MAPK1 2531/4885
US-20190322673-A1 PTERIDINONE COMPOUNDS AND USES THEREOF DPYD, PKD1, TYMP GRN 1022/4885SORT1 4248/4885MAPK1 2266/4885
US-12595233-B2 Thiosemicarbazates and uses thereof TST, THRB, HSPB1 GRN 3920/4885SORT1 4138/4885MAPK1 4390/4885
US-20200354318-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC GRN 4566/4885SORT1 4083/4885MAPK1 4554/4885
US-20230159450-A1 DIMERS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS DNPEP, DAP3, ANPEP GRN 2393/4885SORT1 1166/4885MAPK1 4070/4885
US-20160244415-A1 SUBSTITUTED URACILS AS CHYMASE INHIBITORS UNG, CMA1, TYMP GRN 1111/4885SORT1 4147/4885MAPK1 3345/4885
US-20090258381-A1 Methods for Determining the Cleavability of Substrates CTSF, ADAM17, ADAM10 GRN 2951/4885SORT1 334/4885MAPK1 4278/4885
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF DPYD, PKD1, TYMP GRN 1022/4885SORT1 4248/4885MAPK1 2266/4885
US-12600699-B2 Thiosemicarbazates and uses thereof MET, THRB, ABAT GRN 3136/4885SORT1 4148/4885MAPK1 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback